Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-04-05

Clinical Trial Update: Pulmonic SAPIEN XT THV

View source ↗

Summary

The clinical trial evaluating the Pulmonic SAPIEN XT transcatheter heart valve for pulmonary valve malfunction has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Pulmonic SAPIEN XT THV

Snippet

Sponsor: Institut für Pharmakologie und Präventive Medizin | Conditions: Pulmonary Valve Malfunction | Status: COMPLETED